Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tonlamarsen in Acute Severe Hypertension
NCT07511361Phase 2Recruiting
- Sponsor
- Kardigan
- Start
- Jun 2026
- Primary completion
- Dec 2026
- Modality
- Modified DNA Oligonucleotides, Single-strand DNA, Antisense Oligonucleotides (ASOs)
- Countries
- 1
01
Overview
A Phase 2 trial of tonlamarsen in hypertension (HTN), sponsored by Kardigan. Started Jun 2026; status: recruiting.
02
Drugs
tonlamarsen
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT07511361.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07511361.